AMERICAN CLINICAL LABORATORY ASSN for AMERICAN CLINICAL LABORATORY ASSN

Insurance INS

COVID-19 test coverage and reimbursement

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); White House Office; Centers For Medicare and Medicaid Services (CMS)

Health Issues HCR

Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); White House Office; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); SENATE

Bills named: S. 610 (117th), S. 2209 (117th), H.R. 6119 (117th)

Medicare/Medicaid MMM

Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; White House Office; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC)

Bills named: H.R. 6119 (117th), S. 610 (117th), S. 2209 (117th)

Budget/Appropriations BUD

Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.

Contacted: Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); White House Office; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 2209 (117th), H.R. 6119 (117th), S. 610 (117th)

Disaster Planning/Emergencies DIS

Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); White House Office; Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6119 (117th), S. 610 (117th), S. 2209 (117th)

Medical/Disease Research/Clinical Labs MED

Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, COVID-19 test coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); regulation and oversight of clinical laboratories, including laboratory developed test services; commercial laboratory surge capacity issues for response to COVID-19 pandemic/epidemic/public health crises. H.R. 6119 - Further Extending Government Funding Act. S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act. S.2209 - VALID Act - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of in vitro clinical tests, and for other purposes.

Contacted: Food & Drug Administration (FDA); White House Office; Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2209 (117th), H.R. 6119 (117th), S. 610 (117th)